Browse > Article

Development of a toxA Gene Knock-out Mutant of Pasteurella multocida and Evaluation of its Protective Effects  

Kim Tae-Jung (School of Veterinary and Biomedical Sciences, Murdoch University)
Lee Jae-Il (College of Veterinary Medicine, Chonnam National University)
Lee Bong-Joo (College of Veterinary Medicine, Chonnam National University)
Publication Information
Journal of Microbiology / v.44, no.3, 2006 , pp. 320-326 More about this Journal
Abstract
Pasteurella multocida is an important veterinary and opportunistic human pathogen. In particular, strains of P. multocida serogroup D cause progressive atrophic rhinitis, and produce a potent, intracellular, mitogenic toxin known as P. multocida toxin (PMT), which is encoded by the toxA gene. To further investigate the toxigenic and pathogenic effects of PMT, a toxA-deleted mutant was developed by homologous gene recombination. When administrated to mice, the toxigenicity of the toxA mutant P. multocida was drastically reduced, suggesting that the PMT constributes the major part of the toxigenicity of P, multocida. Similar results were obtained in a subsequent experiment, while high mortalities were observed when toxA(+) P. multocida bacterial culture or culture Iysate were administrated. Mice immunized with toxA(-) P. multocida were not protected (none survived) following challenge with toxA(+) P. multocida or bacterial culture Iysate (toxin). These results suggest that the toxigenicity of P. multocida is mainly derived from PMT.
Keywords
homologous recombination; knock-out; Pasteurella multocida toxin (PMT); toxA;
Citations & Related Records

Times Cited By Web Of Science : 6  (Related Records In Web of Science)
Times Cited By SCOPUS : 6
연도 인용수 순위
1 Chanter, N., 1M. Rutter, and A. Mackenzie. 1986. Partial purification of an osteolytic toxin from Pasteurella multocida. J. Gen. Microbiol. 132, 1089-1097
2 Ciprian, A., T.A. Cruz, and M. de la Garza. 1994. Mycoplasma hyopneumoniae: interaction with other agents in the pigs, and evaluation of immunogens. Arch. Med. Res. 25, 235-239
3 Datsenko, K.A. and B.L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97, 6640-6645
4 de Jong, M.F. 1999. Progressive and nonprogressive atrophic rhinitis, p. 355-384. In B. E. Straw, S. D'Allaire, W. L. Mengeling, and D. J. Taylor (eds.), Diseases of swine, 8th ed. Iowa State University Press, Ames, IA
5 Muller, G., H. Kohler, R. Diller, and W. Erler. 2001. Antibody reactions after aerogenous or subcutaneous immunization of pigs with Pasteurella multocida antigens. Vaccine 19, 751-757   DOI   ScienceOn
6 Nakai, T, A. Sawata, M. Tsuji, Y. Samejima, and K. Kume. 1984. Purification ofdermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D. Infect. Immun. 46, 429-434
7 Smyth, M.G., I.G. Sumner, and A.J. Lax. 1999. Reduced pH causes structural changes in the potent mitogenic toxin of Pasteurella multocida. FEMS Microbiol. Lett. 180, 15-20   DOI
8 Smyth, M.G., R.W. Pickersgill, and A.J. Lax. 1995. The potent mitogen Pasteurella multocidatoxin is highly resistant to proteolysis but becomes susceptible at lysosomal pH. FEBS Lett. 360, 62-66   DOI   ScienceOn
9 Busch, C., J. Orth, N. Djouder, and K. Aktories. 2001. Biological activity of a C-terminal fragment of Pasteurella multocida toxin. Infect. Immun. 69, 3628-3634   DOI   ScienceOn
10 Hoskins, I.C., L.H., Thomas, and AJ. Lax. 1997. Nasal infection with Pasteurella multocidacauses proliferation of bladder epithelium in gnotobiotic pigs. Vet. Rec. 140, 22   DOI   ScienceOn
11 Oswald, E., J.P. Nougayrede, F. Taieb, and M. Sugai. 2005. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 8, 83-91   DOI   ScienceOn
12 Lax, A.J., N. Chanter, G.D. Pullinger, T. Higgins, J.M. Staddon, and E. Rozengurt. 1990. Sequence analysis of the potent mitogenic toxin of Pasteurella multocida. FEBS Lett. 277, 59-64   DOI   ScienceOn
13 Mullan, P.B., and AJ. Lax. 1996. Pasteurella multocidatoxin is a mitogen for bone cells in primary culture. Infect. Immun. 64, 959-965
14 To, H., S. Someno, and S. Nagai. 2005. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs. Am. J. Vet. Res. 66, 113-118   DOI   ScienceOn
15 Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
16 Bagley, K.C., S.P. Abdelwahab, R.G. Tuskan, and G.K. Lewis. 2005. Pasteurella multocida toxin activates human monocyte-derived and murine bone marrow-derived dendritic cells in vitro but suppresses antibody production in vivo. Infect. Immun. 73, 413-421   DOI   ScienceOn
17 Lax, A.J., G.D. Pullinger, M.R. Baldwin, D. Hanney, A.E. Grigoriadis, and 1H. Lakey. 2004. The Pasteurella multocida toxin interacts with signalling pathways to perturb cell growth and differentiation. Int. J. Med. Microbiol. 293, 505-512   DOI   ScienceOn
18 Adler, B., D. Bulach, J. Chung, S. Doughty, M. Hunt, K. Rajakumar, M. Serrano, A. van Zanden, Z. Yamei, and C. Ruffolo. 1999. Candidate vaccine antigens and genes in Pasteurella multocida. J. Biotechnol. 73, 83-90   DOI   ScienceOn
19 Rajeev, S., R.Y. Nair, S.A. Kania, and D.A. Bemis. 2003. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica. Vet. Microbiol. 94, 313-323   DOI   ScienceOn
20 Pullinger, G.D., T Bevir, and A.J. Lax. 2004. The Pasteurella multocida toxin is encoded within a lysogenic bacteriophage. Mol. Microbiol. 51, 255-269   DOI   ScienceOn
21 Lichtensteiger, C.A., S.M. Steenbergen, R.M. Lee, D.D. Polson, and E.R. Vimr. 1996. Direct PCR analysis for toxigenic Pasteurella multocida. J. Clin. Microbiol. 34, 3035-3039
22 Lee, J.M., S.Y. Kang, S.L Park, H.J. Woo, and M.S. Kwon. 2004. Molecular cloning and characterization of the gene for outer membrane protein H in a Pasteurella multocida (D:4) isolate from pigs with atrophic rhinitis symptoms in Korea. J. Microbiol. Biotechnol. 14, 1343-1349
23 Pettit, R.K., M.R. Ackermann, and R.B. Rimler. 1993. Receptor-mediated binding of Pasteurella multocida dermonecrotic toxin to canine osteosarcoma and monkey kidney (vero) cells. Lab. Invest. 69, 94-100
24 Petersen, S.K., and N.T Foged. 1989. Cloning and expression of Pasteurella multocidatoxin gene, toxA, in Escherichia coli. Infect. Immun. 57, 3907-3913
25 Pijoan, C. 1999. Pneumonic pasteurellosis, p. 511-520. In B. E. Straw, S. D'Allaire, W. L. Mengeling, and D. J. Taylor (eds.), Diseases of swine, 8th ed. Iowa State University Press, Ames, IA
26 Ausubel, P.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Strohl. 1996. Current protocols in molecular biology. John Wiley and Sons Inc., NY
27 Pullinger, G.D., R. Sowdhamini, and A.J. Lax. 2001. Localization of functional domains of the mitogenic toxin of Pasteurella multocida. Infect. Immun. 69, 7839-7850   DOI   ScienceOn
28 Hunt, M.L., B. Adler, and K.M. Townsend. 2000. The molecular biology of Pasteurella multocida. Vet. Microbiol. 72, 3-25   DOI   ScienceOn
29 Lax, A.J., and A.E. Grigoriadis. 2001. Pasteurella multocidatoxin: the mitogenic toxin that stimulates signalling cascades to regulate growth and differentiation. Int. J. Med. Microbiol. 291, 261-268   DOI   ScienceOn
30 Rozengurt, E., T. Higgins, N. Chanter, A.J. Lax, and J.M. Staddon. 1990. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc. Natl. Acad. Sci. USA 87, 123-127
31 Haesebrouck, F., F. Pasmans, K. Chiers, D. Maes, R. Ducatelle, and A. Decostere. 2004. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet. Microbiol. 100, 255-268   DOI   ScienceOn
32 Davies, R.L., R. MacCorquodale, S. Baillie, and B. Caffrey. 2003. Characterization and comparison of Pasteurella multocida strains associated with porcine pneumonia and atrophic rhinitis. J. Med. Microbiol. 52, 59-67   DOI   ScienceOn
33 Hodgson, J.C., A. Finucane, M.P. Dagleish, S. Ataei, R. Parton, and J.G. Coote. 2005. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration. Infect. Immun. 73, 1475-1481   DOI   ScienceOn
34 Rutter, J.M., and A. Mackenzie. 1984. Pathogenesis of atrophic rhinitis in pigs, a new perspective. Vet. Rec. 114, 89-90